Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple molecular targets" is not the name of a specific molecule, receptor, or individual biological target. Instead, it refers to a strategy or concept within drug discovery and pharmacology where a drug is designed or known to interact with more than one biological target, which can include various proteins, enzymes, receptors, or pathways[1][2][9]. This concept is central to the field of polypharmacology and systems pharmacology, where the therapeutic effect (and sometimes adverse effects) arises from modulating multiple biological nodes rather than a single, isolated target[1][4][9]. The "multiple molecular targets" label does not specify any unique biomolecule, gene, or receptor, making it unsuitable for use as a canonical molecular entity in a structured database of drug targets. If structured data is desired, each specific molecule or well-defined target should be named individually, not described generically as "multiple molecular targets".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple molecular targets.